PDK2 and cancer: Although numerous mechanisms are responsible for cancer resistance to chemotherapy, an emerging concept suggests that metabolic change in cancer cells may be a critical determinant of resistance that is due, in part, to an attenuated mitochondrial function, which results from the inhibition of PDHC via increased expression of PDK1, PDK2, PDK3, and PDK4 [87, 88].